Hepatitis B virus markers in children with acute leukemia: The effect of chemotherapy
Authors:
- 1 January 1985
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 15 (1) , 29-33
Abstract
Hepatitis B virus markers were tested in the serum of 49 children with acute leukemia on clinical presentation and during subsequent chemotherapy. Hepatitis B surface antigenemia was observed in only six patients (12%), none of whom progressed to chronic infection. Chemotherapy had a marked suppressive effect on the production of antibodies to hepatitis B virus antigens and overt infection occurred in two children after suppression of protective immunity. Evidence of liver damage was frequently observed and was largely independent of serologic data. These results indicate that active immunization with hepatitis B vaccine may not find a clear place in this clinical setting.Keywords
This publication has 5 references indexed in Scilit:
- Chronic liver disease in children with leukemia in long-term remissionCancer, 1983
- HISTOLOGICAL EVIDENCE OF HEPATITIS-B-VIRUS INFECTION WITH NEGATIVE SEROLOGY IN CHILDREN WITH ACUTE LEUKAEMIA WHO DEVELOP CHRONIC LIVER DISEASEThe Lancet, 1982
- The risk of hepatitis transmission to family contacts of leukemia patientsThe Journal of Pediatrics, 1975
- FULMINANT HEPATIC FAILURE IN LEUKAEMIA AND CHORIOCARCINOMA RELATED TO WITHDRAWAL OF CYTOTOXIC DRUG THERAPYThe Lancet, 1975
- Serial Studies of Hepatitis-Associated Antigen and Antibody in Patients Receiving Antitumor Chemotherapy for Myeloproliferative and Lymphoproliferative DisordersGastroenterology, 1975